Cibus CapEx/D&A

What does Cibus do? Cibus, Inc. generates revenue through the development and licensing of plant traits to seed companies, earning royalties on seed sales. The company utilizes its patented RTDS technology platform, including the Trait Machine, a semi-automated trait production facility that accelerates trait development speed, breadth, and scale. Cibus focuses on gene-edited traits indistinguishable from traditional breeding, targeting productivity and sustainable ingredients to address climate change, disease, and pest challenges. Seed companies are the primary buyers of these traits, leveraging Cibus's technology for improved crop performance and sustainability. The company's business model centers on royalties from seed sales, with its RTDS platform enabling efficient trait creation. Cibus emphasizes gene-edited traits that align with traditional breeding outcomes, appealing to seed companies seeking sustainable solutions. The firm's focus on climate resilience, disease resistance, and pest management drives demand for its proprietary technology among seed industry partners. Cibus's revenue stream is derived from licensing agreements with seed companies, where royalties are tied to seed sales. The Trait Machine, part of the RTDS platform, allows for rapid development of traits that enhance crop productivity and sustainability. By addressing key agricultural challenges through gene editing, Cibus positions itself as a provider of innovative solutions for seed companies aiming to meet evolving market demands. Cibus is one of the most popular companies on Eulerpool.